EUVIMEDEUVIMED entdecken
Open Access

Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy

Walter Jackson Iii iD, Yongkang Yang iD, Shaima Salman iD, Dominic Dordai iD, Yajing Lyu iD, Emmanuel Datan, Daiana Drehmer iD, Tina Yi-Ting Huang, Yousang Hwang iD, Gregg L Semenza iD

Science Advances · 30.08.2024 · 10 (35)

DOI: 10.1126/sciadv.adq2366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 30.08.2024. Verfasst von Walter Jackson Iii und 9 weiteren Autor:innen. Beteiligte Einrichtung: Armstrong Oxygen Biology Research Center and Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adoptive cell transfer (ACT) is a therapeutic strategy to augment antitumor immunity. Here, we report that ex vivo treatment of mouse CD8 + T cells with dimethyloxalylglycine (DMOG), a stabilizer of hypoxia-inducible factors (HIFs), induced HIF binding to the genes encoding the costimulatory receptors CD81, GITR, OX40, and 4-1BB, leading to increased expression. DMOG treatment increased T cell killing of melanoma cells, which was further augmented by agonist antibodies targeting each costimulatory receptor. In tumor-bearing mice, ACT using T cells treated ex vivo with DMOG and agonist antibodies resulted in decreased tumor growth compared to ACT using control T cells and increased intratumoral markers of CD8 + T cells (CD7, CD8A, and CD8B1), natural killer cells (NCR1 and KLRK1), and cytolytic activity (perforin-1 and tumor necrosis factor–α). Costimulatory receptor gene expression was also induced when CD8 + T cells were treated with three highly selective HIF stabilizers that are currently in clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveCD8-Positive T-LymphocytesAnimalsMiceAmino Acids, DicarboxylicCell Line, TumorReceptors, OX40Glucocorticoid-Induced TNFR-Related ProteinTumor Necrosis Factor Receptor Superfamily, Member 9Mice, Inbred C57BLMelanoma, ExperimentalHypoxia-Inducible Factor 1, alpha SubunitCytotoxicity, Immunologic

Substanzen

oxalylglycineAmino Acids, DicarboxylicReceptors, OX40Tnfrsf18 protein, mouseGlucocorticoid-Induced TNFR-Related ProteinTnfrsf4 protein, mouseTumor Necrosis Factor Receptor Superfamily, Member 9Hypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Armstrong Oxygen Biology Research Center and Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21205, USA.

ORCID-Profile: Walter Jackson Iii, Yongkang Yang, Shaima Salman, Dominic Dordai, Yajing Lyu, Daiana Drehmer, Yousang Hwang, Gregg L Semenza

Zitieren

APA

Walter Jackson Iii, Yang, Y., Salman, S., Dordai, D., Lyu, Y., Datan, E., Drehmer, D., Huang, T. Y., Hwang, Y., & Semenza, G. L. (2024). Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy. Science Advances, 10(35). https://doi.org/10.1126/sciadv.adq2366

Vancouver

Walter Jackson Iii, Yang Y, Salman S, Dordai D, Lyu Y, Datan E, et al. Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy. Science Advances. 2024;10(35). doi:10.1126/sciadv.adq2366

BibTeX
@article{WalterJacksonIii2024,
  author = {Walter Jackson Iii and Yang, Yongkang and Salman, Shaima and Dordai, Dominic and Lyu, Yajing and Datan, Emmanuel and Drehmer, Daiana and Huang, Tina Yi-Ting and Hwang, Yousang and Semenza, Gregg L},
  title = {Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {35},
  doi = {10.1126/sciadv.adq2366}
}
Kostenlos starten →